Skip to main content
. 2021 May 27;14:1495–1504. doi: 10.2147/JPR.S311573

Figure 3.

Figure 3

(A) Microscopic findings of dexamethasone sodium phosphate (DSP) mixed with 0.75% ropivacaine HCl (ropivacaine) (× 100). (B) Small and short rod-like shaped particulates (≤10 µm) in DSP mixed with ropivacaine (× 200). (C) DSP mixed with 0.75% levobupivacaine HCl (levobupivacaine) (× 100). (D) Small and short particulates in DSP mixed with levobupivacaine (× 200). (E) DSP mixed with hyperbaric bupivacaine HCl (× 100). (F) DSP mixed with 1% lidocaine HCl (× 100). No identifiable particulate is observed.